Literature DB >> 11514367

Bench to bedside: the development of rapamycin and its application to stent restenosis.

S O Marx, A R Marks.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11514367     DOI: 10.1161/01.cir.104.8.852

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  55 in total

Review 1.  Drug-eluting stents for cardiovascular disorders.

Authors:  Juan F Granada; Grzegorz L Kaluza; Albert Raizner
Journal:  Curr Atheroscler Rep       Date:  2003-07       Impact factor: 5.113

2.  Cell-type- and cell-cycle-specific anti-mitogenesis by cicaprost.

Authors:  Paola Castagnino; Devashish Kothapalli; Elizabeth A Hawthorne; Tina Xu; Richard K Assoian
Journal:  Prostaglandins Other Lipid Mediat       Date:  2010-05-10       Impact factor: 3.072

3.  Mammalian target of rapamycin in spinal cord neurons mediates hypersensitivity induced by peripheral inflammation.

Authors:  E Norsted Gregory; S Codeluppi; J A Gregory; J Steinauer; C I Svensson
Journal:  Neuroscience       Date:  2010-06-09       Impact factor: 3.590

4.  Drug eluting stents: maximising benefit and minimising cost.

Authors:  J Gunn; A C Morton; C Wales; C M H Newman; D C Crossman; D C Cumberland
Journal:  Heart       Date:  2003-02       Impact factor: 5.994

5.  Contemporary Use of Drug-eluting Stents.

Authors:  William W Chu; Ron Waksman
Journal:  Curr Treat Options Cardiovasc Med       Date:  2005-05

6.  Profile of Andrew R. Marks.

Authors:  Philip Downey
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-05       Impact factor: 11.205

7.  Oral rapamycin attenuates inflammation and enhances stability of atherosclerotic plaques in rabbits independent of serum lipid levels.

Authors:  Wen Qiang Chen; Lin Zhong; Lei Zhang; Xiao Ping Ji; Mei Zhang; Yu Xia Zhao; Cheng Zhang; Yun Zhang
Journal:  Br J Pharmacol       Date:  2009-03       Impact factor: 8.739

Review 8.  Therapeutic potential of oral antiproliferative agents in the prevention of coronary restenosis.

Authors:  Pramod Kuchulakanti; Ron Waksman
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 9.  Functional diversity and pharmacological profiles of the FKBPs and their complexes with small natural ligands.

Authors:  Andrzej Galat
Journal:  Cell Mol Life Sci       Date:  2012-12-08       Impact factor: 9.261

10.  Effects of drug-eluting stents on systemic inflammatory response in patients with unstable angina pectoris undergoing percutaneous coronary intervention.

Authors:  Nihat Ozer; Burak Tangurek; Fatih Firat; Songul Ozer; Zeynep Tartan; Recep Ozturk; Batuhan Ozay; Figen Ciloglu; Hale Yilmaz; Nese Cam
Journal:  Heart Vessels       Date:  2008-04-04       Impact factor: 2.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.